Market Cap (In USD)
17.17 Million
Revenue (In USD)
2.46 Million
Net Income (In USD)
-14.62 Million
Avg. Volume
6407.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.0-3.89
- PE
- -
- EPS
- -
- Beta Value
- 0.0
- ISIN
- US64134X2018
- CUSIP
- 64134X201
- CIK
- 1933567
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Brian Carrico
- Employee Count
- -
- Website
- https://neuraxis.com
- Ipo Date
- 2023-08-09
- Details
- NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
More Stocks
-
002966Bank of Suzhou Co., Ltd.
002966
-
SHYAMTELShyam Telecom Limited
SHYAMTEL
-
SDRA
-
LAMBODHARALambodhara Textiles Limited
LAMBODHARA
-
OPP-PB
-
BBYB
-
015020E-Starco. Co. Ltd
015020
-
300613